Respiratory syncytial virus (RSV) is a common cause of respiratory infection which mostly affects young children. Most symptoms are usually mild, but some children can get very sick and need hospitalisation.
Vulnerable babies in NSW are eligible to receive an immunisation – called BeyfortusTM (nirsevimab) – to protect them against severe illness from RSV.
These include: babies aged 12 months and under, especially those aged six months and under; young children aged two years and under with medical conditions such as chronic lung disease or congenital heart disease; babies and young children aged two and under who were born pre-term or with a low birth-weight; and Aboriginal and/or Torres Strait Islander infants and children aged two and under.
BeyfortusTM is not a vaccine. It is a type of immunity that occurs when a person is given antibodies rather than making it through their own immune system. It contains pre-made RSV antibodies that protect the body from illness and gives protection almost immediately.
To support the implementation of the BeyfortusTM program, two information sheets for parents and carers are now available.
Immunisation producer Sanofi has also sent information kits to NSW Health facilities. Additional supplies can be ordered using the order form or via the Vaxiplace webpage.
You will need to log in with an AHPRA number if using the site.
Information for parents and carers
Information for parents and carers of Aboriginal babies
Beyfortus Support Materials Order Form